Publication date: November 2026 Source: HPB, Volume 28, Issue 11 Author(s): Wilson M. Alobuia, Susan Tsai, Mary Dillhoff, Timothy M. Pawlik, Alex B. Blair, Vineeth Sukrithan, Bhavana Konda, Jordan M. Cloyd
Defining borderline resectability in pancreatic neuroendocrine tumors and the role of neoadjuvant therapy. // HPB. – URL: https://www.sciencedirect.com/science/article/pii/S1365182X26027450?dgcid=rss_sd_all
Defining borderline resectability in pancreatic neuroendocrine tumors and the role of neoadjuvant therapy. HPB. https://www.sciencedirect.com/science/article/pii/S1365182X26027450?dgcid=rss_sd_all
“Defining borderline resectability in pancreatic neuroendocrine tumors and the role of neoadjuvant therapy.” HPB.
@article{article48174,
title = {Defining borderline resectability in pancreatic neuroendocrine tumors and the role of neoadjuvant therapy},
journal = {HPB},
url = {https://www.sciencedirect.com/science/article/pii/S1365182X26027450?dgcid=rss_sd_all}
}